Amiad: The Industrial Backlog Reset And What It Means For 2026
The main article already showed that the core weakened. This follow-up shows where that weakness sat: the industrial segment. Revenue fell 17.8%, segment profit fell 60.5%, and year-end backlog was down 29.3%.
What This Follow-Up Is Isolating
The main article already established that the core business weakened. This follow-up isolates the exact place where the core really broke: the industrial segment, which is still Amiad’s larger revenue engine but in 2025 stopped being the group’s profit engine.
The short read is this:
- Industrial stayed larger, but stopped leading on profit. Segment revenue was $63.724 million, still above irrigation at $56.536 million, but industrial segment profit fell to only $3.759 million, below irrigation’s $5.276 million.
- This was not just a volume decline. Segment profit fell 60.5%, and segment margin dropped to 5.9% from 12.3% in 2024, before corporate overhead, R&D, finance, and tax.
- The backlog did not just shrink, it became less balanced. Industrial backlog fell to $24.848 million at the end of 2025 from $35.133 million, and within that total the Q2-Q3 layer dropped from $20.693 million to $5.548 million.
That chart captures the whole move. 2024 still looked like a weaker-margin year, but not a broken one. 2025 already looks different: a sharp revenue decline, a collapse in segment profit, and a margin cut to less than half the 2023 level.
The Internal Flip Inside Amiad
The easiest number to miss here is not the revenue decline but the reversal versus irrigation. In 2024 industrial led irrigation by $3.482 million in segment profit. In 2025 it lagged by $1.517 million. In other words, the larger revenue engine turned into the weaker operating-value engine.
| Metric | 2024 | 2025 | Change | What It Means |
|---|---|---|---|---|
| Industrial-segment revenue | 77.484 | 63.724 | (13.760) | Down 17.8% |
| Segment profit | 9.527 | 3.759 | (5.768) | Down 60.5% |
| Segment margin | 12.3% | 5.9% | (6.4 pts) | Sharp erosion in execution quality |
| Year-end backlog | 35.133 | 24.848 | (10.285) | Down 29.3% in forward visibility |
That matters especially because this segment-profit line is still not full group operating profit. It is measured before indirect selling expenses, indirect G&A, R&D, finance, and taxes. So when the number falls to $3.759 million, the message is that the weakness sits inside the segment’s own execution layer, before any head-office burden.
In weight terms, industrial still contributed about 53% of group revenue in 2025, but only about 41.6% of the two segments’ combined segment profit. That is not a modest margin dip. It is a move from industrial carrying the company to industrial still producing most of the revenue while no longer producing most of the operating contribution.
This Was Pressure On Both Volume And Execution
If this had been only a broad demand slowdown, one would expect a fairly even decline across the segment’s revenue layers. That is not what the filing shows. Inside industrial, network-filtration products actually rose to $24.755 million from $23.240 million, while the “other” line fell to $27.309 million from $40.201 million, and media products fell to $7.141 million from $9.092 million.
That waterfall sharpens the point: the weakness was not uniform. One product line held up, but it was nowhere near enough to offset the sharp fall in the “other” line and the decline in media. That is why reading 2025 as if it were just one weak quarter hidden inside the annual numbers misses the real issue. The pressure ran deeper and hit meaningful parts of the segment.
Management ties the revenue decline to economic uncertainty that delayed infrastructure projects. In the industry discussion it points specifically to a significant slowdown in North America and the freezing of major infrastructure investments, while other regions also slowed, though less severely. On profitability, the picture is even less comfortable: the company points to higher production costs in Israel and Turkey, shekel appreciation against the dollar, and in the same industry discussion also to low profitability on several projects because implementation costs came in above plan.
That is the key point. The 2025 problem was both volume and execution. Orders weakened, and some of the work that did get executed produced materially lower profitability. So 2026 requires Amiad not only to refill the order book, but also to prove that returning volume can again turn into reasonable segment profit.
2026 Opened With A Narrower Backlog Base
Backlog is where the 2026 read becomes concrete. At the end of 2024 Amiad closed the year with $35.133 million of industrial backlog. At the end of 2025 that number was already down to $24.848 million. But the total alone is not the full story. The real change sits in how that backlog is distributed across the year.
At first glance there are even layers that improved. Q1 rose to $10.606 million from $8.801 million, and Q4 jumped to $8.534 million from $3.227 million. That is exactly why this chart matters: it shows that the hole opened in the middle of the year. The combined Q2-Q3 layer fell to $5.548 million from $20.693 million, a 73.2% decline. The 2026/2027 layer also almost disappeared.
That does not mean revenue must collapse in mid-2026, because the company can still win new orders. It does mean the year opened from a less comfortable base. At the end of 2024, the backlog gave broader coverage into the following quarters. At the end of 2025, much more of the work is pushed onto new orders that still need to be won.
Even close to the report date, industrial backlog remained similar to the year-end level, meaning the gap was not quickly closed at the start of 2026. At the broader company level, management also states explicitly that Amiad entered 2026 with a lower order backlog than in 2025, mainly because of the decline in industrial backlog. That sentence explains well why 2026 opens here as a proof year rather than a normal continuation year.
Why This Makes 2026 A Proof Year
Amiad says it is continuing to introduce automation, improve work and planning processes, and drive manufacturing and product efficiency. It also says sales growth and better operating efficiency will remain central in 2026. That is exactly why the industrial segment needs to be judged this year on two separate axes:
- Backlog replenishment: especially in the middle layers of the year, after infrastructure-project freezes and North American weakness.
- Margin repair: because even if revenue recovers partly, a 5.9% segment margin is not enough to restore industrial as a profit engine.
There is a fair counter-read. Industrial is still the larger segment by revenue, network products did grow in 2025, the Q1 backlog layer improved, and the company is already acting on efficiency in Israel and Turkey. If delayed projects start moving again and those efficiency steps flow into the cost base, 2025 could still prove to be a trough year rather than a new normal.
But that is exactly the right 2026 distinction. For the constructive read to hold, Amiad needs to show not only that backlog refills, but that it refills without another year of weak execution and thin project economics. Until those two conditions arrive together, 2025 looks less like a one-off stumble and more like a reset year for the industrial segment.
Bottom Line
The thesis of this follow-up is simple: Amiad’s industrial segment entered a reset in 2025. It is still the larger revenue engine, but segment profit collapsed, industrial lost its internal lead over irrigation, and backlog opened 2026 from a smaller and less balanced base.
This is not necessarily a permanent thesis about segment quality. It is a thesis about the 2026 starting point. If Amiad can refill new orders, especially into the middle of the year, and at the same time show that efficiency in Israel and Turkey is lifting segment profit again, the reading of 2025 can change quickly. If not, the last year will look, in hindsight, not like a minor cyclical stumble but like the year in which the company’s larger revenue engine lost both visibility and quality.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.